On November 14, the International Neuroethics Society convened for its annual meeting at the AAAS building in Washington, D.C. I had the pleasure of attending and presenting at INS through the generous support of the Emory Neuroethics Program. The society is an interdisciplinary group of scholars - including lawyers, clinicians, researchers, and policy makers - and the 2014 agenda reflected this diversity in expertise.
The conference opened with a short talk by Chaka Fattah, the U.S. representative for Pennsylvania’s 2nd congressional district. As a Philadelphia native, I was excited to learn that Congressman Fattah was an architect of the Fattah Neuroscience Initiative, which was an impetus for developing the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative.
|Courtesy of Gillian Hue|
Discussion of the BRAIN initiative continued through the following panels, “The BRAIN Initiative & the Human Brain Project: an Ethical Focus” and “The Future of Neuroscience Research & Ethical Implications”. Panelist Stephen Hauser spoke about the Presidential Commission for the Study of Bioethical Issues, while Henry Markram discussed the Human Brain Project – the European-based research collaboration to establish innovative neurotechnologies and develop a more thorough understanding of the human brain. Representatives of several scientific funding institutions (Dr. Tom Insel – Director of the National Institute of Mental Health, Dr. George Koob – Director of the National Institute on Alcohol Abuse and Alcoholism, and Dr. Geoff Ling – Defense Advanced Research Projects Agency) discussed the progress of neuroscience research, while emphasizing the need for continued advancement. Although the morning panels were interesting (as a behavioral neuroscientist, seeing Dr. Tom Insel was quite thrilling), I was left with the impression that the scientific “establishment” was only beginning to scratch the surface of the neuroethical implications of the research being conducted by scientists like myself. I wondered if any of the morning panelists attended the later sessions, which discussed more neuroethically hard-hitting issues, such as “Neuroscience in the Courts” and “Neuroscience and Human Rights”.